Cargando…
Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome
BACKGROUND: Treatment with Trastuzumab is associated with cardiotoxicity. If Trastuzumab could be administered in a safe manner to patients who develop a reduced left ventricular ejection fraction (EF) of < 50% remains poorly understood. OBJECTIVE: To evaluate the impact of a cardioncological app...
Autores principales: | Fabiani, Iacopo, Cipolla, Carlo Maria, Colombo, Nicola, Cardinale, Daniela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417864/ https://www.ncbi.nlm.nih.gov/pubmed/32848791 http://dx.doi.org/10.3389/fphar.2020.01190 |
Ejemplares similares
-
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology
por: Fabiani, Iacopo, et al.
Publicado: (2019) -
Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia
por: Pillai, Sneha S., et al.
Publicado: (2022) -
Interventions for Preventing Cardiotoxicity in Breast Cancer Patients Receiving Trastuzumab: A Systemic Review and Bayesian Network Meta-Analysis
por: Li, Xinyi, et al.
Publicado: (2021) -
SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients
por: Quagliariello, Vincenzo, et al.
Publicado: (2020)